PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs

BackgroundsEpidermal growth factor receptor (EGFR) mutation profiles play a vital role in treatment strategy decisions for non–small cell lung cancer (NSCLC). The purpose of this study was to evaluate the predictive efficacy of baseline 18F-FDG PET/CT-based radiomics analysis for EGFR mutation statu...

Full description

Bibliographic Details
Main Authors: Liping Yang, Panpan Xu, Mengyue Li, Menglu Wang, Mengye Peng, Ying Zhang, Tingting Wu, Wenjie Chu, Kezheng Wang, Hongxue Meng, Lingbo Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.894323/full